arimoclomol

Orphazyme agrees to sell itself, and its 'pipeline-in-a-product,' to KemPharm
Endpoints
Mon, 05/16/22 - 10:20 am
Orphazyme
KemPharm
M&A
arimoclomol
FDA rejects Orphazyme's rare disease drug, continuing wild ride for Danish meme stock
Fierce Biotech
Fri, 06/18/21 - 10:17 am
FDA
Orphazyme
Niemann-Pick disease
arimoclomol
FDA Action Alert: Blueprint, Orphazyme and Eton
BioSpace
Mon, 06/14/21 - 10:52 am
FDA
Blueprint Medicines
avapritinib
Orphazyme
arimoclomol
Eton Pharmaceuticals